{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:34:15Z","timestamp":1761586455653,"version":"build-2065373602"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["312698\/2018-6"],"award-info":[{"award-number":["312698\/2018-6"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.intimp.2021.107405","type":"journal-article","created":{"date-parts":[[2021,1,30]],"date-time":"2021-01-30T05:44:32Z","timestamp":1611985472000},"page":"107405","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["IgE antibodies to hepatitis C virus core and nonstructural antigens in chronic hepatitis C patients before and after antiviral treatment"],"prefix":"10.1016","volume":"93","author":[{"given":"Jo\u00e3o Paulo C.G.","family":"Silva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Larissa S.","family":"Jesus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Isabel Schinoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabela S.","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Luiza B.S.","family":"Atta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ajax M.","family":"Atta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"unstructured":"World Health Organization, Hepatitis C. Who 2020, https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-c.","key":"10.1016\/j.intimp.2021.107405_b0005"},{"issue":"5\u20136","key":"10.1016\/j.intimp.2021.107405_b0010","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.micinf.2019.06.008","article-title":"The remarkable history of the hepatitis C virus","volume":"21","author":"Pol","year":"2019","journal-title":"Microbes Infect."},{"unstructured":"World Health Organization, Combating hepatitis B and C to reach elimination by 2030: advocacy brief. World Health Organization, 2016. https:\/\/apps.who.int\/iris\/handle\/10665\/206453.","key":"10.1016\/j.intimp.2021.107405_b0015"},{"issue":"RR-2","key":"10.1016\/j.intimp.2021.107405_b0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6902a1","article-title":"CDC recommendations for hepatitis C screening among adults \u2014 United States, 2020","volume":"69","author":"Schillie","year":"2020","journal-title":"MMWR Recomm. Rep."},{"issue":"2","key":"10.1016\/j.intimp.2021.107405_b0025","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1002\/hep.31060","article-title":"AASLD-IDSA Hepatitis C Guidance Panel. Hepatitis C guidance 2019 update: American association for the study of liver diseases-infectious diseases society of America recommendations for testing, managing, and treating hepatitis C virus infection","volume":"71","author":"Ghany","year":"2020","journal-title":"Hepatology."},{"issue":"1","key":"10.1016\/j.intimp.2021.107405_b0030","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1086\/380202","article-title":"Occult hepatitis C virus infection in patients in whom the etiology of persistently abnormal results of liver-function tests is unknown","volume":"189","author":"Castillo","year":"2004","journal-title":"J. Infect. Dis."},{"issue":"2","key":"10.1016\/j.intimp.2021.107405_b0035","first-page":"155","article-title":"Occult hepatitis C virus infection: a review","volume":"6","author":"Austria","year":"2018","journal-title":"J ClinTranslHepatol."},{"unstructured":"C. Lange, C. Sarrazin, Hepatitis C: diagnostic tests, in: S. Mauss, T. Berg, J. Rockstroh, C. Sarrazin, H. Wedemeyer (Eds.), Hepatology: A clinical textbook, 10th ed., 2020, pp. 241\u2013264. www.hepatologytextbook.com.","key":"10.1016\/j.intimp.2021.107405_b0040"},{"issue":"1","key":"10.1016\/j.intimp.2021.107405_b0045","first-page":"43","article-title":"IgE anti-varicella zoster virus and other immune responses before, during, and after shingles","volume":"39","author":"Smith-Norowitz","year":"2009","journal-title":"Ann. Clin. Lab Sci."},{"issue":"3","key":"10.1016\/j.intimp.2021.107405_b0050","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/eji.201747052","article-title":"Respiratory viral infections and atopic development: from possible mechanisms to advances in treatment","volume":"48","author":"Martorano","year":"2018","journal-title":"Eur. J. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2021.107405_b0055","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1089\/088922202753519142","article-title":"HIV type 1-specific IgE in serum of long-term surviving children inhibits HIV type 1 production in vitro","volume":"18","author":"Pellegrino","year":"2002","journal-title":"AIDS Res. Hum Retroviruses."},{"issue":"3","key":"10.1016\/j.intimp.2021.107405_b0060","first-page":"444","article-title":"Liver disease\u2013a prominent cause of serum IgE elevation","volume":"23","author":"Van Epps","year":"1976","journal-title":"Clin. Exp. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2021.107405_b0065","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.imlet.2015.09.004","article-title":"IL17A gene polymorphism, serum IL17 and total IgE in Egyptian population with chronic HCV and hepatocellular carcinoma","volume":"168","author":"ELBassuoni","year":"2015","journal-title":"Immunol. Lett."},{"issue":"2","key":"10.1016\/j.intimp.2021.107405_b0070","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/hep.510240201","article-title":"An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group","volume":"24","author":"Bedossa","year":"1996","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.intimp.2021.107405_b0075","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1373\/clinchem.2007.090134","article-title":"A critical appraisal of current practice in the detection, analysis, and reporting of cryoglobulins","volume":"54","author":"Vermeersch","year":"2008","journal-title":"Clin. Chem."},{"issue":"1\u20132","key":"10.1016\/j.intimp.2021.107405_b0080","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0022-1759(98)00170-7","article-title":"A statistically defined endpoint titer determination method for immunoassays","volume":"221","author":"Frey","year":"1998","journal-title":"J. Immunol. Methods."},{"key":"10.1016\/j.intimp.2021.107405_b0085","doi-asserted-by":"crossref","first-page":"e20180491","DOI":"10.1590\/0037-8682-0491-2018","article-title":"IgG1 and IgG4 antibodies against Core and NS3 antigens of hepatitis C virus","volume":"52","author":"Santos","year":"2019","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"10.1016\/j.intimp.2021.107405_b0090","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.cyto.2017.09.015","article-title":"Immune response of Th17-associated cytokines by peripheral blood mononuclear cells from patients with chronic hepatitis C virus infection","volume":"102","author":"Cabral","year":"2018","journal-title":"Cytokine"},{"issue":"7053","key":"10.1016\/j.intimp.2021.107405_b0095","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/nature04078","article-title":"Evasion of intracellular host defence by hepatitis C virus [published correction appears in Nature. 2005 Sep 8;437(7056):290]","volume":"436","author":"Gale","year":"2005","journal-title":"Nature"},{"issue":"14","key":"10.1016\/j.intimp.2021.107405_b0100","doi-asserted-by":"crossref","first-page":"10792","DOI":"10.1074\/jbc.M610361200","article-title":"Functional and therapeutic analysis of hepatitis C virus NS3.4A protease control of antiviral immune defense","volume":"282","author":"Johnson","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"1 Suppl","key":"10.1016\/j.intimp.2021.107405_b0105","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1016\/j.jhep.2014.07.027","article-title":"Global epidemiology and genotype distribution of the hepatitis C virus infection","volume":"61","author":"Gower","year":"2014","journal-title":"J. Hepatol."},{"key":"10.1016\/j.intimp.2021.107405_b0110","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/1743-422X-6-84","article-title":"Hepatitis C virus core, NS3, NS4B and NS5A are the major immunogenic proteins in humoral immunity in chronic HCV infection","volume":"6","author":"Sillanp\u00e4\u00e4","year":"2009","journal-title":"Virol. J."},{"issue":"11","key":"10.1016\/j.intimp.2021.107405_b0115","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1038\/jid.2010.175","article-title":"Interleukin-17A promotes IgE production in human B cells","volume":"130","author":"Milovanovic","year":"2010","journal-title":"J. Invest. Dermatol."},{"issue":"1","key":"10.1016\/j.intimp.2021.107405_b0120","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.humimm.2008.10.021","article-title":"Interleukin-21 stimulates B-cell immunoglobulin E synthesis in human beings concomitantly with activation-induced cytidine deaminase expression and differentiation into plasma cells","volume":"70","author":"Kobayashi","year":"2009","journal-title":"Hum. Immunol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576921000412?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576921000412?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:30:23Z","timestamp":1761586223000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576921000412"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":24,"alternative-id":["S1567576921000412"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2021.107405","relation":{},"ISSN":["1567-5769"],"issn-type":[{"type":"print","value":"1567-5769"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IgE antibodies to hepatitis C virus core and nonstructural antigens in chronic hepatitis C patients before and after antiviral treatment","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2021.107405","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107405"}}